Business Description
Becton, Dickinson and Co
NAICS : 339112
SIC : 3841
ISIN : US0758874061
Share Class Description:
BDXB.PFD: PRF PERPETUAL USD 50 - 1/20TH INT Ser BTotal Employee Number:
72,000Compare
Compare
Traded in other countries / regions
BDX.USABDX.Mexico0R19.UKBOX.GermanyBDX.Austria1BDX.ItalyB1DX34.BrazilBDX.Switzerland IPO Date
2020-05-20Description
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 3.66 | |||||
Interest Coverage | 5.08 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.01 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.9 | |||||
3-Year EBITDA Growth Rate | 3.8 | |||||
3-Year EPS without NRI Growth Rate | 8.3 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | 2.39 | |||||
12-1 Month Momentum % | -2.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 122.06 | |||||
Days Sales Outstanding | 46.74 | |||||
Days Payable | 63.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 6.1 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 9.04 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.79 | |||||
Operating Margin % | 14.48 | |||||
Net Margin % | 5.33 | |||||
EBITDA Margin % | 22.09 | |||||
ROE % | 4.53 | |||||
ROA % | 2.1 | |||||
ROIC % | 5.6 | |||||
3-Year ROIIC % | 41.41 | |||||
ROC (Joel Greenblatt) % | 26.38 | |||||
ROCE % | 4.92 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 40.02 | |||||
Forward PE Ratio | 29.79 | |||||
PE Ratio without NRI | 11.76 | |||||
Shiller PE Ratio | 30.83 | |||||
Price-to-Owner-Earnings | 17.88 | |||||
PEG Ratio | 1.53 | |||||
PS Ratio | 2.11 | |||||
PB Ratio | 1.8 | |||||
Price-to-Free-Cash-Flow | 14.8 | |||||
Price-to-Operating-Cash-Flow | 11.81 | |||||
EV-to-EBIT | 26.63 | |||||
EV-to-EBITDA | 12.72 | |||||
EV-to-Revenue | 2.81 | |||||
EV-to-FCF | 19.63 | |||||
Earnings Yield (Greenblatt) % | 3.76 | |||||
FCF Yield % | 7.02 | |||||
Forward Rate of Return (Yacktman) % | 8.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BDXB.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Becton, Dickinson and Co Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.23 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 10.84 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.6625 | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | -2.15 | ||
| 52-Week Range ($) | 45.85 - 52.52 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton, Dickinson and Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Becton, Dickinson and Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-11-25 | In 144 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 126 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-06 | In 125 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-07 08:00 | In 35 days | ||
| Third quarter earnings results for 2026 | 2026-08-07 | In 34 days | ||
| Bank of America Securities Health Care Conference | 2026-05-12 11:40 | -- | ||
| Second quarter earnings conference call for 2026 | 2026-05-07 08:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-05-07 | -- | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-10 08:30 | -- | ||
| First quarter earnings conference call for 2026 | 2026-02-09 08:00 | -- |
Show
Entries
Becton, Dickinson and Co Frequently Asked Questions
What is Becton, Dickinson and Co(BDXB.PFD)'s stock price today?
The current price of BDXB.PFD is $48.16. The 52 week high of BDXB.PFD is $52.52 and 52 week low is $45.85.
When is next earnings date of Becton, Dickinson and Co(BDXB.PFD)?
The next earnings date of Becton, Dickinson and Co(BDXB.PFD) is 2026-08-07 Est..
Does Becton, Dickinson and Co(BDXB.PFD) pay dividends? If so, how much?
Becton, Dickinson and Co(BDXB.PFD) does not pay dividend.
Guru Commentaries on NYSE:BDXB.PFD
No articles.
Press Release
Articles on Becton, Dickinson and Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers